IMA
NASDAQ · Pharmaceuticals
Imagenebio Inc
$5.77
+0.06 (+1.05%)
Open$5.76
Previous Close$5.71
Day High$5.80
Day Low$5.53
52W High$16.47
52W Low$3.94
Volume—
Avg Volume10.4K
Market Cap64.18M
P/E Ratio—
EPS$-5.40
SectorPharmaceuticals
Analyst Ratings
Buy
7 analysts
Price Target
+108.3% upside
Current
$5.77
$5.77
Target
$12.02
$12.02
$8.98
$12.02 avg
$15.27
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.83M | 4.92M | 44.29M |
| Net Income | -103,554,998 | -250,941,029 | 4.55M |
| Profit Margin | -5,668.6% | -5,385.2% | 10.3% |
| EBITDA | -109,727,011 | -280,669,521 | 9.89M |
| Free Cash Flow | — | — | 3.33M |
| Rev Growth | -62.9% | -62.9% | -0.9% |
| Debt/Equity | — | — | 0.50 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |